Cargando…
Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529
The HIV-1-envelope (Env) spike is a conformational machine that transitions between prefusion (closed, CD4-bound, CCR5-bound) and postfusion states to facilitate HIV-1 entry. Although the prefusion-closed conformation is a potential target for inhibition, development of small molecule leads has been...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676566/ https://www.ncbi.nlm.nih.gov/pubmed/28825711 http://dx.doi.org/10.1038/nchembio.2460 |
_version_ | 1783277080486608896 |
---|---|
author | Pancera, Marie Lai, Yen-Ting Bylund, Tatsiana Druz, Aliaksandr Narpala, Sandeep O’Dell, Sijy Schön, Arne Bailer, Robert T. Chuang, Gwo-Yu Geng, Hui Louder, Mark K. Rawi, Reda Soumana, Djade I. Finzi, Andrés Herschhorn, Alon Madani, Navid Sodroski, Joseph Freire, Ernesto Langley, David R. Mascola, John R. McDermott, Adrian B. Kwong, Peter D. |
author_facet | Pancera, Marie Lai, Yen-Ting Bylund, Tatsiana Druz, Aliaksandr Narpala, Sandeep O’Dell, Sijy Schön, Arne Bailer, Robert T. Chuang, Gwo-Yu Geng, Hui Louder, Mark K. Rawi, Reda Soumana, Djade I. Finzi, Andrés Herschhorn, Alon Madani, Navid Sodroski, Joseph Freire, Ernesto Langley, David R. Mascola, John R. McDermott, Adrian B. Kwong, Peter D. |
author_sort | Pancera, Marie |
collection | PubMed |
description | The HIV-1-envelope (Env) spike is a conformational machine that transitions between prefusion (closed, CD4-bound, CCR5-bound) and postfusion states to facilitate HIV-1 entry. Although the prefusion-closed conformation is a potential target for inhibition, development of small molecule leads has been stymied by difficulties in obtaining structural information. Here, we report crystal structures at 3.8-Å resolution of HIV-1-Env trimer with BMS-378806 and its derivative, BMS-626529, for which a prodrug version is currently in Phase III-clinical trials. Both lead candidates recognized an induced-binding pocket, which was mostly excluded from solvent and comprised of Env elements from a conserved helix and the β20-21-hairpin. In both structures, the β20-21-region assumed a conformation distinct from prefusion-closed and CD4-bound states. Together with biophysical and antigenicity characterizations, the structures illuminate the allosteric and competitive mechanisms whereby these small-molecule leads inhibit CD4–induced structural changes in Env. |
format | Online Article Text |
id | pubmed-5676566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-56765662018-02-21 Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 Pancera, Marie Lai, Yen-Ting Bylund, Tatsiana Druz, Aliaksandr Narpala, Sandeep O’Dell, Sijy Schön, Arne Bailer, Robert T. Chuang, Gwo-Yu Geng, Hui Louder, Mark K. Rawi, Reda Soumana, Djade I. Finzi, Andrés Herschhorn, Alon Madani, Navid Sodroski, Joseph Freire, Ernesto Langley, David R. Mascola, John R. McDermott, Adrian B. Kwong, Peter D. Nat Chem Biol Article The HIV-1-envelope (Env) spike is a conformational machine that transitions between prefusion (closed, CD4-bound, CCR5-bound) and postfusion states to facilitate HIV-1 entry. Although the prefusion-closed conformation is a potential target for inhibition, development of small molecule leads has been stymied by difficulties in obtaining structural information. Here, we report crystal structures at 3.8-Å resolution of HIV-1-Env trimer with BMS-378806 and its derivative, BMS-626529, for which a prodrug version is currently in Phase III-clinical trials. Both lead candidates recognized an induced-binding pocket, which was mostly excluded from solvent and comprised of Env elements from a conserved helix and the β20-21-hairpin. In both structures, the β20-21-region assumed a conformation distinct from prefusion-closed and CD4-bound states. Together with biophysical and antigenicity characterizations, the structures illuminate the allosteric and competitive mechanisms whereby these small-molecule leads inhibit CD4–induced structural changes in Env. 2017-08-21 2017-10 /pmc/articles/PMC5676566/ /pubmed/28825711 http://dx.doi.org/10.1038/nchembio.2460 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Pancera, Marie Lai, Yen-Ting Bylund, Tatsiana Druz, Aliaksandr Narpala, Sandeep O’Dell, Sijy Schön, Arne Bailer, Robert T. Chuang, Gwo-Yu Geng, Hui Louder, Mark K. Rawi, Reda Soumana, Djade I. Finzi, Andrés Herschhorn, Alon Madani, Navid Sodroski, Joseph Freire, Ernesto Langley, David R. Mascola, John R. McDermott, Adrian B. Kwong, Peter D. Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 |
title | Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 |
title_full | Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 |
title_fullStr | Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 |
title_full_unstemmed | Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 |
title_short | Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529 |
title_sort | crystal structures of trimeric hiv env with entry inhibitors bms-378806 and bms-626529 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676566/ https://www.ncbi.nlm.nih.gov/pubmed/28825711 http://dx.doi.org/10.1038/nchembio.2460 |
work_keys_str_mv | AT panceramarie crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT laiyenting crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT bylundtatsiana crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT druzaliaksandr crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT narpalasandeep crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT odellsijy crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT schonarne crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT bailerrobertt crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT chuanggwoyu crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT genghui crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT loudermarkk crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT rawireda crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT soumanadjadei crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT finziandres crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT herschhornalon crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT madaninavid crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT sodroskijoseph crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT freireernesto crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT langleydavidr crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT mascolajohnr crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT mcdermottadrianb crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 AT kwongpeterd crystalstructuresoftrimerichivenvwithentryinhibitorsbms378806andbms626529 |